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Introduction
Childhood obesity and various obesity-related co-
morbidities have become a serious global healthcare
problem. Predictive risk stratification and early detection
of high-risk obese youths can potentially help modify
the outcomes of obesity before irreversible damage tak-
ing place. Newer surrogate markers for assessing pre-
clinical cardiovascular alterations have good predictive
values for future cardiovascular risks. However, local
data regarding obesity-related arterial alterations in
youth are lacking at present.
Aims
To evaluate the 1) pre-clinical cardiovascular alterations;
and 2) their associations with the metabolic profiles in
obese Hong Kong Chinese youths.
Study methods
A total of 56 obese subjects and 58 healthy lean controls
(M: F 1:1, age 17.0 ± 2.06 years) were recruited. Clinical,
biochemical and arterial (structural and functional)
parameters were obtained from all participants. Struc-
tural arterial parameters were determined by assessing
carotid arterial intima-media thickness with ECG-syn-
chronized ultrasound (Vivid 7, GE Medical Systems,
Norway). Cross-sectional and regional arterial functions
were determined by assessing the arterial stiffness (b) of
carotid arteries and pulse wave velocities of various
arterial segments respectively with an automatic device
(VP-2000; Colin Medical Technology, Japan). All ultra-
sonographic and arterial assessments were performed by
a single researcher.
Results
Obese youths have worse preclinical arterial phenotypes both
structurally and functionally, hence higher risks of develop-
ing cardiovascular disease in the future (p<0.0001). Impor-
tant independent risk factors for preclinical arterial
alterations in obese youths, including body mass indices
(BMI), waist circumferences, blood pressures and plasma ala-
nine aminotransferase (ALT) levels were demonstrated
(p<0.0001). Obese youths having co-morbid metabolic dis-
turbances were associated with worse preclinical arterial phe-
notypes. The worst cardiovascular phenotypes were shown
in obese youths with the highest triglycerides to high-density
lipoproteins (Tg-to-HDL) ratios despite most of them having
normal serum triglyceride and HDL levels. Furthermore,
obese subjects with higher paediatric NAFLD fibrosis index
(PNFI) scores [1] have worse cross-sectional arterial stiffness.
Conclusions
Assessment of preclinical cardiovascular phenotypes in
asymptomatic obese youths provides clinicians a window
for early identification of those at higher risks of devel-
oping future cardiovascular events. Evaluation of lipid
compositions and obesity-related liver alterations may
potentially help further stratify obese youths into sub-
groups with different degrees of cardiovascular risks.
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